Are pretomanid-containing regimens for TB a victory or a victory narrative?

"Given the evidence base available to us currently, can we claim pretomanid a victory? We think more research is needed before pretomanid can be celebrated as a promising treatment for people with tuberculosis."

Read More →

Time to lower the price of Xpert cartridges to US$ 5

Advocates request Cepheid immediately reduce the price of Xpert tests to US$ 5, inclusive of service and maintenance; the company responds they are “not able to predict the amount of further reductions or when they may be available.”

Read More →

Survivors Statement

Presented in the Opening Ceremony of the 50th Union World Conference on Lung Health by survivor Nandita Venkatesan.

Read More →

WHO updates policy for the use of TB LAM test

The World Health Organization now recommends more broader use of urinary LAM assays for diagnosis of TB in people living with HIV.

Read More →

TAG’s 2019 Pipeline Report: Three TB sections released

The sections provide an overview of TB diagnostics, vaccines and treatment.

Read More →

Public investments in TB medicine bedaquiline far exceed those of developer Johnson & Johnson

Quantification of investments in the development of bedaquiline finds total public and philanthropic expenditures are three to five times those of Johnson & Johnson.

Read More →

Protestors demand Cepheid halve the price of GeneXpert TB tests to US$5

The high cost of GeneXpert tests for TB leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert.

Read More →

Civil society statement on rifapentine price discount

A lower price for rifapentine is just a start — communities need more than discounts to access TB preventive therapy!

Read More →

TB activists disrupt opening of The Union Conference to protest drug corporations keeping life-saving medicines from people

Newer medicines for drug-resistant TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. 

Read More →

Civil society demands affordability, transparency and accountability from the TB Alliance

Civil society activists storm the stage at The Union Conference to demand affordability, transparency and accountability from the TB Alliance.

Read More →

Page 1 of 101 · Total posts: 10

1 2 Last→